UNIVERSAL DISPLAY CORP quarterly report, Q1 FY2020

Universal Display Corporation — Q1 2020 Form 10-Q Summary

Business context and reporting period

Universal Display Corporation develops, licenses and commercializes OLED technologies and materials for display and lighting applications. Revenue is generated primarily from OLED material sales, intellectual-property licensing and royalties, technology support, and Adesis contract research services. The unaudited filing covers the three months ended March 31, 2020, compared with the three months ended March 31, 2019.

Key financial metrics

MetricQ1 2020Q1 2019Change
Revenue$112.3 million$87.8 million+28.0%
Gross profit$89.8 million$72.0 million+24.8%
Gross margin80.0%82.0%Down 2.0 percentage points
Operating income$44.5 million$34.4 million+29.5%
Operating margin39.6%39.1%Up 0.5 percentage points
Net income$38.2 million$31.5 million+21.2%
Net margin34.0%35.9%Down 1.9 percentage points
Diluted EPS$0.80$0.66+21.2%
Operating cash flow$5.7 million$34.1 millionDown $28.3 million

OLED material sales represented 98% of revenue, compared with 97% in the prior-year quarter; Adesis and other services represented the remainder. Revenue outside North America was 98% of total revenue. South Korea contributed $69.4 million and China contributed $37.8 million.

Liquidity, capital structure and cash flow

  • Cash and cash equivalents were $222.7 million at March 31, 2020, compared with $131.6 million at December 31, 2019.
  • Short-term investments were $417.0 million, down from $514.5 million at year-end. Total cash and short-term investments were $639.8 million versus $646.1 million at December 31, 2019.
  • Working capital increased to $675.5 million from $630.9 million.
  • The filing does not disclose outstanding debt or borrowings; total liabilities were $289.7 million.
  • Operating cash flow was reduced by increases in accounts receivable of $22.1 million and inventory of $10.7 million, and decreases in accounts payable and accrued expenses of $29.3 million. Deferred revenue increased $43.7 million.
  • Investing activities provided $97.0 million, primarily reflecting $101.8 million of net investment sales. Capital expenditures were $4.8 million.
  • Financing activities used $11.7 million, including $7.1 million of dividends and $4.8 million of employee tax-withholding payments. The quarterly common dividend was $0.15 per share, and a second-quarter dividend of $0.15 per share was declared on May 5, 2020.

Material changes versus the prior comparable period

  • Revenue increased $24.5 million, which management attributed primarily to customer inventory-management efforts related to potential U.S.-China trade tensions and anticipated supply disruptions from COVID-19.
  • Gross profit increased $17.9 million, but gross margin declined from 82% to 80%, partly reflecting higher inventory reserves.
  • Research and development expense rose $3.7 million to $19.5 million, primarily from higher employee-related compensation and contract research activity.
  • Selling, general and administrative expense increased $3.4 million to $15.4 million, primarily due to higher employee-related compensation.
  • Royalty and license expense increased $0.7 million to $3.3 million due to higher qualifying material sales. Inventory reserves increased to $0.6 million from $0.2 million.
  • Interest income declined $0.7 million to $2.1 million because of lower bond yields.
  • Operating cash flow fell substantially despite higher net income, mainly because of working-capital movements and the timing of deferred-revenue recognition.

Guidance, outlook, risks and unusual items

  • Management stated that COVID-19 had a limited impact on first-quarter operations and results, but expected adverse effects on revenue, net income and cash flow for at least the balance of 2020. Potential impacts include weaker customer demand, retail closures, supply-chain and logistics disruptions, lower productivity, and deteriorating consumer and macroeconomic conditions.
  • The company had not experienced a significant inability to fulfill customer shipments as of the filing date, but stated that continued logistics and supply-chain performance was uncertain.
  • Management expects existing cash, cash equivalents and short-term investments to fund obligations for at least the next 12 months, subject to COVID-19 developments and internal assumptions.
  • Q1 2020 included recognition of previously constrained revenue after a customer’s March 15, 2020 return right expired without exercise. The related prior shipment had been deferred because of uncertainty regarding customer production needs, trade tensions and international health conditions.
  • Three customers represented 41%, 25% and 23% of revenue, respectively, creating substantial customer concentration. Substantially all chemical materials were purchased from one supplier.
  • The company had $149.4 million of deferred revenue, $5.2 million of phosphorescent-emitter backlog expected to be fulfilled within 90 days, and $24.9 million of inventory purchase commitments.
  • An opposition proceeding involving European Patent No. 1390962, relating to white phosphorescent OLED technology, was scheduled for an appeal hearing in the third quarter of 2020. The company stated that the outcome could require significant resources, although it did not expect the proceeding to materially affect the business as a whole.
  • The company is pursuing Korean withholding-tax claims and related U.S. tax adjustments. The filing includes significant long-term tax assets and liabilities, and states that estimates may change upon settlement.
  • The 2006 research agreement with USC and the University of Michigan was extended through April 30, 2023; remaining potential payments were up to $9.1 million as of March 31, 2020.

Important facts for investors to verify

  • Whether the Q1 revenue increase reflected sustainable demand or temporary customer inventory buildup and catch-up recognition.
  • The duration and severity of COVID-19 effects on OLED customers, consumer electronics demand, supply chains and future cash flow.
  • Customer concentration, particularly the identities, financial condition and purchasing trends of the three customers representing 89% of Q1 revenue in aggregate.
  • Changes in gross margin, inventory reserves, accounts receivable and deferred revenue as customer demand normalizes.
  • The status and financial implications of Korean withholding-tax litigation, mutual-agreement proceedings and related U.S. tax obligations.
  • The outcome of the European Patent Office appeal and the continuing cost of patent defense and prosecution.
  • The company’s ability to sustain dividends while operating cash flow remains materially below reported net income.